
Group B streptococcus prevalence, serotype distribution and colonization dynamics in Western Australian pregnant women
Author(s) -
Lucy L. Furfaro,
Elizabeth Nathan,
Barbara J. Chang,
Matthew S. Payne
Publication year - 2019
Publication title -
journal of medical microbiology/journal of medical microbiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.91
H-Index - 117
eISSN - 1473-5644
pISSN - 0022-2615
DOI - 10.1099/jmm.0.000980
Subject(s) - serotype , medicine , group b , cohort , streptococcus , meningitis , colonization , transmission (telecommunications) , streptococcus agalactiae , sepsis , pregnancy , gestation , neonatal sepsis , pediatrics , obstetrics , immunology , biology , microbiology and biotechnology , electrical engineering , bacteria , genetics , engineering
Streptococcus agalactiae, or group B streptococcus (GBS), is a leading neonatal pathogen that causes sepsis, meningitis and pneumonia. Globally, strategies have been implemented to address vertical transmission, and in Western Australia (WA), culture-based screening at 35-37 weeks' gestation is part of routine care and guides antibiotic administration. Previous Australian studies have focused on other regions or included low sample-size representatives; we aimed to describe antenatal GBS colonization in WA.